Background: pain is prevalent in frail older adults; however, the association of pain and frailty has not been evaluated yet by a systematic assessment of prospective longitudinal studies. Objective: we aimed to assess the association of persistent pain as a risk factor for frailty incidence, using data from longitudinal studies in a systematic review and meta-analysis. Methods: publications were identified using a systematic search on PubMed, Embase, Cochrane Library and clinicaltrials. gov databases from inception to October 2017. Since heterogeneity across studies was high, we used random-effects metaanalysis to calculate the pooled relative risk for the association between persistent pain and the incidence of frailty. We investigated sources of heterogeneity among studies using meta-regression and stratified analyses. Results: we included five prospective longitudinal studies with 13,120 participants (46% women, mean age from 59 to 85 years old). Participants with persistent pain at baseline had twice the risk of developing frailty during the follow-up (pooled RR = 2.22, 95% CI = 1.14-4.29). No variables were related to study heterogeneity in sensitivity analyses. Conclusion: persistent pain was a risk factor for the development of frailty in a meta-analysis of longitudinal studies. Better understanding of the association between pain and frailty with proper evaluation of potential confounders could allow the development of targeted interventions.
Introduction
The prevalence of pain is high in the general population, and it increases with age, ranging from 40% in communitydwelling older adults to 80% in institutionalised individuals [1] [2] [3] [4] . However, this prevalence may be underestimated due to challenges related to the assessment of pain in older people, especially in the presence of cognitive impairment [5, 6] . The presence of pain in older people, especially persistent pain (i.e. a painful experience that continues for a prolonged period of time that may or may not be associated with a recognisable disease process) has already been associated with several adverse outcomes, such as depression, social isolation, anxiety, insomnia, falls, higher health costs, weight loss, greater vulnerability to stressors, functional loss and low quality of life [7, 8] .
Frailty, as initially defined by Fried et al., is a spiral energy decline due to sarcopenia and neuroendocrine and immune dysfunctions [9] . Frailty is a multidimensional geriatric syndrome in which there is a state of increased vulnerability to stressors and greater difficulty in returning to homoeostasis due to a decline in the physiological reserve in neuromuscular, metabolic and immunological systems [9] . Several criteria have been validated in the literature for the diagnosis of frailty [10] [11] [12] [13] , but the most widely used is still the phenotypic criterion [9] . In a recent meta-analysis of frailty prevalence with 61,500 participants, frailty was present in 10.7% of community-dwelling older adults, with a variation of 4.0-59.1% in different studies [14] . Frailty is an important prognostic factor for several adverse outcomes in the older people, such as hospitalisation, institutionalisation, falls, functional loss and mortality [14, 15] . Moreover, several risk factors are associated with the development and progression of frailty, such as smoking, heavy alcohol use, obesity, depression, diabetes mellitus and cardiovascular diseases [14, 15] .
The association between pain and frailty was recently described in a systematic review [16] . Overall, frailty was associated with pain with odds ratios (OR) ranging from 3.9 to 5.5; however, no conclusion about the directionality of this association was possible. Since then, some longitudinal studies have shown that the presence of chronic pain at baseline was associated with an increased risk of developing frailty [17] [18] [19] . However, these studies evaluated specific populations (e.g. male cohorts) (Wade et al., 2016) or participants with specific comorbities (e.g. osteoarthritis) (Veronese et al., 2017) . Because pain is a treatable condition, defining whether it is a risk factor and not simply a consequence of frailty can pave the way for targeted screening, preventive and therapeutic interventions in older adults. Therefore, we aimed to assess the association of persistent pain and frailty incidence, using data from longitudinal studies in a systematic review and meta-analysis.
Methods
The review protocol was registered in PROSPERO (CRD42017081183) [20] .
Search strategy
The Meta-analysis of Observational Studies in Epidemiology was followed to conduct the current systematic review and meta-analysis, and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was used as a reporting guideline (please see Appendix D in Supplementary data, available in Age and Ageing online) [21, 22] . We searched the PubMed, Embase, Cochrane Library and clinicaltrials.gov databases from inception to October 2017, with the help of a librarian to devise the search strategy. (please see Appendix B for full search strategy in Supplementary data, available in Age and Ageing online). We did not apply any restrictions regarding language while performing the manuscript searches. We also checked for references in relevant review articles, and we conducted a citation search among the references of all articles included in this meta-analysis.
Study inclusion and exclusion
A Mendeley (Version 1.17.11, Mendeley Ltd) library was created to store all the studies retrieved in the electronic databases, and we removed duplicate citations using Mendeley. Two coauthors (M.D.S. and G.S.S.) independently reviewed the titles and abstracts of the retrieved citations. Studies were excluded if there was no indication that they were investigating the longitudinal association of pain as a risk factor for frailty. Discrepancy was resolved by consensus. Then, full texts of the selected citations were assessed independently for inclusion eligibility by the same coauthors and using the same strategy. We included longitudinal studies, randomised clinical trials, systematic reviews and metaanalyses. We excluded editorials, case reports, descriptive and cross-sectional studies.
We identified studies reporting pain at the baseline in older adults that included a validated frailty measurement assessed in the baseline and during the follow-up. The two main validated models of frailty are the phenotype [9] and the cumulative deficit models [11] . The phenotype model, first described by Fried et al. [9] , includes five criteria, any three of which mark a person as recognisably frail: unintentional weight loss, self-reported exhaustion, weakness (grip strength), slow walking speed and low physical activity. On the other hand, the cumulative deficit models are based on the accumulation of deficits and its criteria include the presence and/or severity of current diseases, ability in activities of daily living, and physical signs from the clinical and neurological examinations. We excluded studies that only reported a frailty indicator measurement (e.g. timed up-andgo test or gait speed). For pain assessment, we included studies reporting persistent pain [7] . We excluded studies that evaluated acute, oncological or postoperative pain.
Data extraction
Two coauthors (M.D.S. and S.M.L.) independently read and extracted data from the included full-text citations. We contacted the authors if the required data were unclear in the manuscript. For each study included in this meta-analysis, we extracted the number of participants with and without pain, who did not have the diagnosis of frailty at baseline (i.e. robust and pre-frail participants). Then, we extracted the number of participants who had developed frailty during the follow-up by pain status (i.e. participants with and without pain at baseline). We also extracted additional information regarding publication year, country where the study was performed, total number of participants, study design, study follow-up time, mean age of participants, number of female participants, scale used to evaluate pain, instrument used to determine the frailty status, depressive symptoms, cognitive impairment evaluation, body mass index (BMI) and information on other potential confounders.
Quality assessment and risk of bias
Quality assessment and risk of bias of the eligible studies were performed by two coauthors (M.D.S. and S.M.L.) using the Newcastle-Ottawa Quality Assessment Form for Cohort Studies (NOS) [23, 24, 25] . The NOS include eight multiple-choice questions from three broad domains: four items related to the selection of study groups, one item related to the comparability of study groups and three items related to the assessment of outcomes. The NOS has a maximum score of 9 [23] .
Statistical analysis
After data extraction, we pooled relative risks (RR) for the association between pain and frailty status using the metan command in Stata 12 (StataCorp LP, 2011, College Station, TX), which presents pooled RR and the 95% confidence interval using the Mantel-Haenszel method [26] . Heterogeneity across studies was assessed using the Q-test and the I 2 statistics. Heterogeneity was present if the P-value for the Q-test was below 0.05 or if the I 2 was above 50% [27] . Since a significant heterogeneity was present, we performed a randomeffects model meta-analysis, as recommended.
We performed sensitivity analyses to investigate the source of heterogeneity among studies. Sensitivity analyses were defined a priori, considering differences in the study designs and participant characteristics. Moreover, we excluded one study at a time and recalculated the pooled RR to evaluate whether the meta-analysis results were biased by any individual study. We performed stratified analyses according to the following: (1) study characteristics: study quality high risk of bias versus low or moderate risk of bias [23] , sample size (n < 1,000 and n ≥ 1,000), adjusted versus unadjusted analysis and length of follow-up <5 and ≥5 years (median follow-up time among included studies); (2) instrument used to evaluate frailty: fried phenotype frailty models versus cumulative deficit models; (3) pain assessment: well-defined versus not well-defined pain location and duration assessment and (4) participant characteristics: mean age <70 and ≥70 years old, sex (one study with only men versus other studies with more than 50% of women) and prevalence of depressive symptoms <40% and ≥40% (based on the estimated prevalence of depressive symptoms in older people in a recent meta-analysis) [28] . We also used the Stata user-command metareg, which performs random-effects meta-regressions, using study-level data to explore whether each of these variables was related to study heterogeneity.
Results

Selected studies
One thousand and forty-two articles were initially identified from databases. After removal of duplicates and exclusion of papers that were not relevant to this research question (i.e. editorials, case reports, descriptive and cross-sectional studies), 36 manuscripts were selected for full-text review. After the full-text review, 31 studies were excluded, and five studies were eligible for this report. No other relevant study was found in review articles or after a careful review of references from all articles included in this meta-analysis. Figure 1 describes the study selection process.
Across the five included studies, there were 13,120 participants (baseline mean age ranged from 59 to 85 years old, and 46% were women), with study sample sizes ranging from 290 to 5,316 (Table 1 ). All studies were prospective cohorts conducted in Europe, and they had mean followup times ranging from 3 to 8 years. Three studies were specifically designed to evaluate the longitudinal association of pain and frailty and performed adjusted analysis for potential confounders [17] [18] [19] . The other two studies were longitudinal cohorts that included the evaluation of pain and frailty at baseline and during the follow-up and did not perform adjusted statistical analyses for confounders [29, 30] . One study included only male participants [17] . After quality assessment and risk of bias by NOS (Table 2) , the LUCAS study [29] was considered high risk of bias, Pro. V. A. [19] and Octabaix [30] studies were considered moderate risk (due to the lack of representativeness of the cohort), and EMAS [17] and ELSA [18] studies were considered low risk of bias. Pain was evaluated by different scales among studies; however, only two studies defined well the duration and location of pain [17, 19] , and only one evaluated its intensity on a scale [18] . Frailty was assessed by Fried modified frailty phenotype models in two studies [19, 30] and by cumulative deficit models in three studies [17, 18, 29] . Mean BMI varied from 26.9 (7.3) to 27.7 (4.0) kg/m 2 among studies. Depressive symptoms were evaluated by different scales (Table 1) , and the prevalence of these symptoms was over 40% in two studies [19, 30] . The prevalence of cognitive impairment was described in only two studies, where it varied from 5.2% [30] to 10.4% [19] . Only one study excluded participants with cognitive impairment from recruitment [29] . The summary information of the eligible studies is described in Table 2 .
Meta-analysis
We performed a random-effects model meta-analysis to investigate the association between pain and frailty, since the heterogeneity across studies was high (Q-test = 23.03, df = 4, P < 0.0001 and I 2 = 82.6%). Participants with pain at the baseline had twice the risk of developing frailty by the end of follow-up (pooled RR = 2.22, 95% CI = 1.14-4.29) (Figure 2) .
To clarify the reasons for heterogeneity, we performed a series of sensitivity analyses. When we performed an influence analysis, excluding one study at a time, the association between pain and incident frailty remained significant, except when excluding the EMAS or LUCAS studies (see Table S1 , Appendix A in Supplementary data, available in Age and Ageing online).
In meta-regression analyses, follow-up time (P = 0.71), adjusted analysis for confounders (P = 0.86), risk of bias measured by the NOS (P = 0.83), sample size (P = 0.94), instrument used to evaluate frailty (P = 0.16), well-defined pain (P = 0.65), mean age of participants (P = 0.10), studies with only men (P = 0.33) and depressive symptoms (P = 0.06) were unrelated to study heterogeneity in metaregression analyses. Neither test for publication bias was significant (Egger's test: t = −0.75, P = 0.51; Begg's test: z = −0.24, P = 1.00), and the funnel plot showed no sign of publication bias upon visual inspection (see Figure S1 , Appendix A in Supplementary data, available in Age and Ageing online). We also performed stratified analyses to investigate whether certain characteristics were related to study heterogeneity (see Figure S2 , Appendix A in Supplementary data, available in Age and Ageing online).
Discussion and Conclusion
This systematic review and meta-analysis is the first to examine the association between pain at baseline and the incidence of frailty during the follow-up period using information from prospective longitudinal studies. Our study shows that persistent pain is a risk factor for frailty, since the presence of pain was associated with twice the risk of developing frailty during the follow-up.
Although the number of studies about pain in the older people is increasing, there are few studies in the literature that correlate pain with frailty. Both pain and frailty prevalence increase considerably with advancing age, and both are associated with functional decline and have a negative impact on the quality of life in this population [7, 8, 14, 15] . In fact, the association between pain and frailty was recently described in a systematic review of cross-sectional and longitudinal studies [16] . Overall, frailty was significantly associated with pain in these studies, even after adjustment for several confounders such as age, gender, BMI, marital status, depression, education, comorbidities, and physical activity. Another important factor observed in these studies is that this association is dose-responsive, showing that the association with frailty increases with the severity of pain [3, 16] . However, the systematic review by Brown et al. (2015) highlighted that no inference about the directionality of this association was possible at that time due to a lack of adequate prospective studies, and that future research should address this gap. Unfortunately, we could not draw conclusion about a dose-response of pain and incidence of frailty since only one study included in our meta-analysis evaluated the intensity of pain [31] .
The presence of pain may contribute to and/or accelerate the process of frailty in older adults through the following mechanisms: reduction of mobility and physical activity, depression, social isolation, reduction of nutritional intake, and presence of comorbidities [3, 8, 16] . These changes could leave older adults more vulnerable and less able to effectively adapt to physiologic stressors, a phenomenon that has recently been proposed and called 'pain homeostenosis' [3] . On the other hand, frailty may be associated with modifications in the perception of pain and its exacerbation due to neurologic, skeletal, immune, and endocrine changes. Age-related changes in the neurophysiology of nociception, including the reduced efficacy of the endogenous analgesic system and descending inhibitory pathways of pain, have also been described [8, 16, 45, 46] .
Moving forward with this concept, some support the idea that pain should be incorporated into the frailty criteria, given that pain may be an additional manifestation of the pathophysiological changes of frailty [8] . Indeed, the addition of pain assessment to the phenotypic frailty criteria improved the accuracy of the Fried frailty scale in predicting adverse outcomes such as death, fall, hospitalisation, institutionalisation and functional disability in this population [8] .
It is important to note that frail individuals are at increased risk of developing delirium, cognitive impairment and Odds ratio (OR) for the association between pain at baseline and incidence of frailty.
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dementia, which are conditions in which pain assessment and treatment are challenging [16] . However, we noticed in our systematic review that few studies investigated the presence of cognitive impairment [19, 30] , and future studies on this topic should face this issue. In addition, due to comorbidities, polypharmacy, increased risk of adverse drug events and challenges in pain evaluation, the use of analgesics by frail patients with pain is still unfortunately low [5, 16, 47] . Thus, an adequate understanding of the mechanisms of pain in frail older adults is an important step in the development of specific interventions for this population. Untreated pain in frail patients may reduce the effectiveness of frailty treatment, which aims to strengthen and provide adequate nutritional support. Moreover, different pain management strategies in this population may be important for the prevention, slowing of progression, or even improvement of frailty, and it should be incorporated as a central element in frailty interventions [8, 16] . Our study had a number of strengths. The prospective data, which were derived from representative cohorts, included standardised methods and validated questionnaire instruments. Besides the few studies that correlated the longitudinal association between pain and frailty, our study has a large number of participants. Nevertheless, our study should be interpreted while considering some limitations. An important point is the lack of standardisation in the evaluation of pain and frailty in the studies included in this review. In most of the studies, the type (nociceptive, neuropathic, mixed), aetiology, intensity, duration and place of pain were not characterised. Moreover, none of the studies used a multidimensional geriatric specific scale or a dementia specific scale for pain assessment as recommended in recent guidelines [7, 48] . Although the Fried phenotypic frailty criteria are the most-used in the literature, other evaluation criteria for frailty based on an index of deficit accumulation [11] were observed in studies of this review [17, 18, 29] . It is important to note that both approaches to evaluate frailty were considered good instruments for detecting adverse outcomes [11] . As mood disorders are known to influence pain experience in older patients [7] , all of the studies evaluated depressive symptoms by different scales. Interestingly, the prevalence of depressive symptoms was borderline associated as a source of heterogeneity in our meta-analysis (P = 0.06). However, pain was only associated with frailty in participants with low prevalence of depression, which is not in accordance with previous findings [16, 49] . This could be explained by the fact that all included studies reported only the prevalence of depressive symptoms and not the prevalence of major depression. In addition, the use of antidepressants was not reported. Another relevant limitation is the lack of complete data on the evaluation of anxiety, dementia and on the use of analgesics in the studies included in this review. Moreover, not all studies had adjusted analyses for other potential confounders. Finally, all included studies are from European cohorts, which compromises, in part, the external validity of our findings. Therefore, new prospective studies with well-defined cohorts from other locations are needed to better understand the association between pain and frailty. Moreover, randomised controlled trials are extremely important to evaluate and compare specific multimodal interventions for pain treatment and their effects on frailty prevention.
In conclusion, in this systematic review and metaanalysis using data from a large number of participants from longitudinal studies, it was found that persistent pain was a risk factor for the development of frailty. Figure 2 . Forest plot of the relative risks (RR) and 95% confidence intervals (CI) from a random-effects meta-analysis for the association between pain at the baseline and incidence of frailty during the follow-up. For each study, the size of the grey square is indicative of the relative weight each study carried in the meta-analysis. The rhombi represent the pooled RR for this association.
Key points
• Both pain and frailty prevalence increase considerably with advancing age, and both are associated with functional decline and have a negative impact on the quality of life.
• The longitudinal association between persistent pain and frailty has not yet been investigated using a systematic approach.
• In this systematic review and meta-analysis of five prospective longitudinal studies (n = 13,120), persistent pain was associated with approximately twice the risk of developing frailty.
• Persistent pain may contribute to and/or accelerate the process of frailty through reduction of mobility, depression, social isolation and reduction of nutritional intake.
• Better understanding of the association between pain and frailty could allow the development of targeted interventions.
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